VRTX compared with QNT: revenue, margins and what each company keeps, and the suppliers and customers both name

VRTXVertex Pharmaceuticals Inc

Mkt capRevenueRevenue

QNTQuantinuum Inc.

Mkt capRevenueRevenue

Compare

VRTXVertex Pharmaceuticals Inc

QNTQuantinuum Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

VRTXVertex Pharmaceuticals Inc

558.99▲+3.52%· post 558.00

Mkt cap$141.7BRevenue$3.3BQ2 FY26Revenue$12.0BFY25

QNTQuantinuum Inc.

33.68▼−10.17%· post 33.95

ClosedOct 30 '26

Mkt cap$1.1BRevenue$8MQ2 FY26Revenue—

Compare

ClosedOct 30 '26

VRTXVertex Pharmaceuticals Inc

QNTQuantinuum Inc.

558.99▲+3.52%post 558.00

Price

33.68▼−10.17%post 33.95

$141.7B

Mkt cap

$1.1B

Q2 FY26$3.3B

Revenue

$8MQ2 FY26

FY25$12.0B

Revenue

—

VRTX558.99▲+3.52%vsQNT33.68▼−10.17%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

VRTX, solidQNT, dashed

Supply-chain overlap

Revenue flow

QNT: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VRTX 10

MRNAModernasupplier

CRSPCRISPR Therapeuticssupplier

SEPNSepternasupplier

EDITEditas Medicinesupplier

6 more · VRTX chain ›

Shared 0

No shared counterparties.

Only QNT 3

JPMJPMorgan Chasecustomer

AMGNAmgencustomer

—Mitsuiunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR